Previous Article | Next Article 
Journal of Virology, September 2000, p. 7834-7841, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Involvement of the Zinc-Binding Capacity of Sendai
Virus V Protein in Viral Pathogenesis
Cheng
Huang,1
Katsuhiro
Kiyotani,1
Yutaka
Fujii,1
Noriko
Fukuhara,1
Atsushi
Kato,2,
Yoshiyuki
Nagai,2,
Tetsuya
Yoshida,1 and
Takemasa
Sakaguchi1,*
Department of Bacteriology, Hiroshima
University School of Medicine, Hiroshima
734-8551,1 and Department of Viral
Infection, Institute of Medical Science, University of Tokyo, Tokyo
108-8639,2 Japan
Received 1 March 2000/Accepted 30 May 2000
The V protein of Sendai virus (SeV) is nonessential to virus
replication in cell culture but indispensable to viral pathogenicity in
mice. The highly conserved cysteine-rich zinc finger-like domain in its
carboxyl terminus is believed to be responsible for this viral
pathogenicity. In the present study, we showed that the cysteine-rich
domain of the SeV V protein could actually bind zinc by using
glutathione-S-transferase fusion proteins. When the seven
conserved cysteine residues at positions 337, 341, 353, 355, 358, 362, and 365 were replaced individually, the zinc-binding capacities of the
mutant proteins were greatly impaired, ranging from 22 to 68% of that
of the wild type. We then recovered two mutant SeVs from cDNA, which
have V-C341S and V-C365R mutations and
represent maximal and minimal zinc-binding capacities among the
corresponding mutant fusion proteins, respectively. The mutant viruses
showed viral protein synthesis and growth patterns similar to those of
wild-type SeV in cultured cells. However, the mutant viruses were
strongly attenuated in mice in a way similar to that of SeV
V
C, which has a truncated V protein lacking the
cysteine-rich domain, by exhibiting earlier viral clearance from the
mouse lung and less virulence to mice. We therefore conclude that the
zinc-binding capacity of the V protein is involved in viral pathogenesis.
*
Corresponding author. Mailing address: Department of
Bacteriology, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Phone: 81-82-257-5157. Fax: 81-82-257-5159. E-mail:
takemasa{at}mcai.med.hiroshima-u.ac.jp.

Present address: Department of Viral Diseases and Vaccine Control,
National Institute of Infectious Diseases, Musashi-Murayama
208-0011,
Japan.

Present address: AIDS Research Center, National Institute of
Infectious Diseases, Tokyo 162-8640,
Japan.
Journal of Virology, September 2000, p. 7834-7841, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kato, A., Kiyotani, K., Kubota, T., Yoshida, T., Tashiro, M., Nagai, Y.
(2007). Importance of the Anti-Interferon Capacity of Sendai Virus C Protein for Pathogenicity in Mice. J. Virol.
81: 3264-3271
[Abstract]
[Full Text]
-
Mehle, A., Thomas, E. R., Rajendran, K. S., Gabuzda, D.
(2006). A Zinc-binding Region in Vif Binds Cul5 and Determines Cullin Selection. J. Biol. Chem.
281: 17259-17265
[Abstract]
[Full Text]
-
Hui, E. K.-W., Smee, D. F., Wong, M.-H., Nayak, D. P.
(2006). Mutations in Influenza Virus M1 CCHH, the Putative Zinc Finger Motif, Cause Attenuation in Mice and Protect Mice against Lethal Influenza Virus Infection.. J. Virol.
80: 5697-5707
[Abstract]
[Full Text]
-
Kato, A., Cortese-Grogan, C., Moyer, S. A., Sugahara, F., Sakaguchi, T., Kubota, T., Otsuki, N., Kohase, M., Tashiro, M., Nagai, Y.
(2004). Characterization of the Amino Acid Residues of Sendai Virus C Protein That Are Critically Involved in Its Interferon Antagonism and RNA Synthesis Down-Regulation. J. Virol.
78: 7443-7454
[Abstract]
[Full Text]
-
Huang, Z., Krishnamurthy, S., Panda, A., Samal, S. K.
(2003). Newcastle Disease Virus V Protein Is Associated with Viral Pathogenesis and Functions as an Alpha Interferon Antagonist. J. Virol.
77: 8676-8685
[Abstract]
[Full Text]
-
Modrof, J., Becker, S., Muhlberger, E.
(2003). Ebola Virus Transcription Activator VP30 Is a Zinc-Binding Protein. J. Virol.
77: 3334-3338
[Abstract]
[Full Text]
-
Park, M.-S., Shaw, M. L., Munoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., Garcia-Sastre, A., Basler, C. F.
(2002). Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins. J. Virol.
77: 1501-1511
[Abstract]
[Full Text]
-
Yokosawa, N., Yokota, S.-i., Kubota, T., Fujii, N.
(2002). C-Terminal Region of STAT-1{alpha} Is Not Necessary for Its Ubiquitination and Degradation Caused by Mumps Virus V Protein. J. Virol.
76: 12683-12690
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Kato, A., Ohnishi, Y., Hishiyama, M., Kohase, M., Saito, S., Tashiro, M., Nagai, Y.
(2002). The Amino-Terminal Half of Sendai Virus C Protein Is Not Responsible for either Counteracting the Antiviral Action of Interferons or Down-Regulating Viral RNA Synthesis. J. Virol.
76: 7114-7124
[Abstract]
[Full Text]
-
Sakaguchi, T., Uchiyama, T., Huang, C., Fukuhara, N., Kiyotani, K., Nagai, Y., Yoshida, T.
(2002). Alteration of Sendai Virus Morphogenesis and Nucleocapsid Incorporation due to Mutation of Cysteine Residues of the Matrix Protein. J. Virol.
76: 1682-1690
[Abstract]
[Full Text]
-
Kato, A., Ohnishi, Y., Kohase, M., Saito, S., Tashiro, M., Nagai, Y.
(2001). Y2, the Smallest of the Sendai Virus C Proteins, Is Fully Capable of both Counteracting the Antiviral Action of Interferons and Inhibiting Viral RNA Synthesis. J. Virol.
75: 3802-3810
[Abstract]
[Full Text]
-
Parks, C. L., Lerch, R. A., Walpita, P., Wang, H.-P., Sidhu, M. S., Udem, S. A.
(2001). Comparison of Predicted Amino Acid Sequences of Measles Virus Strains in the Edmonston Vaccine Lineage. J. Virol.
75: 910-920
[Abstract]
[Full Text]